Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities

Epidemics

Volumn 7, Issue , 2014, Pages 22-27

  Ndeffo Mbah, Martial L ^a   Gilbert, Jennifer A ^a   Galvani, Alison P ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Female genital schistosomiasis; HIV; Mathematical modeling; Praziquantel; Schistosoma haematobium

Indexed keywords

PRAZIQUANTEL; ANTHELMINTIC AGENT;

ANGOLA; ARTICLE; CHILD; CHILDHOOD DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; KENYA; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MIXED INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SCHOOL CHILD; VIRUS TRANSMISSION; ZAMBIA; ADOLESCENT; ANIMAL; BIOLOGICAL MODEL; CHEMOPROPHYLAXIS; COINFECTION; FEMALE; HIV INFECTIONS; INCIDENCE; ORGANIZATION AND MANAGEMENT; PREVALENCE; PREVENTIVE HEALTH SERVICE; PROCEDURES; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; SCHOOL HEALTH SERVICE; SEX RATIO;

ADOLESCENT; ANGOLA; ANIMALS; ANTHELMINTICS; CHEMOPREVENTION; CHILD; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; KENYA; MODELS, BIOLOGICAL; PRAZIQUANTEL; PREVALENCE; PREVENTIVE HEALTH SERVICES; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; SCHOOL HEALTH SERVICES; SEX DISTRIBUTION; ZAMBIA;

EID: 84901197645     PISSN: 17554365     EISSN: 18780067     Source Type: Journal    
DOI: 10.1016/j.epidem.2014.04.002     Document Type: Article

References (39)

1. Cohen M.S., Chen Y.Q., McCauley M., Gamble T., Hosseinipour M.C., Kumarasamy N., et al. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 2011, 365(August (6)):493-505.
2. Croce D., Porazzi E., Foglia E., et al. Cost-effectiveness of a successful schistosomiasis control programme in Cambodia (1995-2006). Acta Trop. 2010, 113(3):279-284.
3. Donnell D., Baeten J.M., Kiarie J., Thomas K.K., Stevens W., Cohen C.R., et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010, 375(June (9731)):2092-2098.
4. Downs J.A., Mguta C., Kaatano G.M., Mitchell K.B., Bang H., Simplice H., et al. Urogenital schistosomiasis in women of reproductive age in Tanzania's Lake Victoria region. Am. J. Trop. Med. Hyg. 2011, 84(March (3)):364-369.
5. Fenwick A. The global burden of neglected tropical diseases. Public Health 2012, 126(March (3)):233-236.
6. French M.D., Churcher T.S., Gambhir M., et al. Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study. PLoS Negl. Trop. Dis. 2010, 4(11):e897.
7. Fulford A.J., Webster M., Ouma J.H., Kimani G., Dunne D.W. Puberty and age-related changes in susceptibility to schistosome infection. Parasitol. Today 1998, 14(January (1)):23-26.
8. Gabrielli A.-F., Montresor A., Chitsulo L., Engels D., Savioli L. Preventive chemotherapy in human helminthiasis: theoretical and operational aspects. Trans. R. Soc. Trop. Med. Hyg. 2011, 105(December (12)):683-693.
9. Garnett G.P., Bartley L., Grassly N.C., Anderson R.M. Antiretroviral therapy to treat and prevent HIV/AIDS in resource-poor settings. Nat. Med. 2002, 8(July (7)):651-654.
10. Goldman A.S., Guisinger V.H., Aikins M., Amarillo M.L.E., Belizario V.Y., Garshong B., et al. National mass drug administration costs for lymphatic filariasis elimination. PLoS Negl. Trop. Dis. 2007, 1(October (31)).
11. Hotez P.J., Fenwick A., Kjetland E.F. Africa's 32 cents solution for HIV/AIDS. PLoS Negl. Trop. Dis. 2009, 3(May (5)).
12. Hotez P.J., Fenwick A. Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Negl. Trop. Dis. 2009, 3(September (9)). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746322/ (cited 29.6.12).
13. Kallestrup P., Zinyama R., Gomo E., Butterworth A.E., Mudenge B., Van Dam G.J., et al. Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. J. Infect. Dis. 2005, 192(December (11)):1956-1961.
14. King C.H., Muchiri E.M., Ouma J.H. Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya. Emerg. Infect. Dis. 2000, 6(6):585-594.
15. King C.H., Dickman K., Tisch D.J. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005, 365(May (9470)):1561-1569.
16. King C.H., Olbrych S.K., Soon M., Singer M.E., Carter J., Colley D.G. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review. PLoS Negl. Trop. Dis. 2011, 5(September (9)):e1321.
17. Kjetland E.F., Ndhlovu P.D., Gomo E., Mduluza T., Midzi N., Gwanzura L., et al. Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS 2006, 20(February (4)):593-600.
18. Kjetland E.F., Mduluza T., Ndhlovu P.D., Gomo E., Gwanzura L., Midzi N., et al. Genital schistosomiasis in women: a clinical 12-month in vivo study following treatment with praziquantel. Trans. R. Soc. Trop. Med. Hyg. 2006, 100(August (8)):740-752.
19. Kjetland E.F., Ndhlovu P.D., Kurewa E.N., Midzi N., Gomo E., Mduluza T., et al. Prevention of gynecologic contact bleeding and genital sandy patches by childhood anti-schistosomal treatment. Am. J. Trop. Med. Hyg. 2008, 79(1):79-83.
20. Kjetland E.F., Leutscher P.D.C., Ndhlovu P.D. A review of female genital schistosomiasis. Trends Parasitol. 2012, 28(February (2)):58-65.
21. Lillerud L.E., Stuestoel V.M., Hoel R.E., Rukeba Z., Kjetland E.F. Exploring the feasibility and possible efficacy of mass treatment and education of young females as schistosomiasis influences the HIV epidemic. Arch. Gynecol. Obstet. 2010, 281(March (3)):455-460.
22. Marino S., Hogue I.B., Ray C.J., Kirschner D.E. A methodology for performing global uncertainty and sensitivity analysis in systems biology. J. Theor. Biol. 2008, 254(September (1)):178-196.
23. Mbabazi P.S., Andan O., Fitzgerald D.W., Chitsulo L., Engels D., Downs J.A. Examining the relationship between urogenital schistosomiasis and HIV infection. PLoS Negl. Trop. Dis. 2011, 5(December (12)):e1396.
24. Muchiri E.M., Ouma J.H., King C.H. Dynamics and control of Schistosoma haematobium transmission in Kenya: an overview of the Msambweni Project. Am. J. Trop. Med. Hyg. 1996, 55(November (5 Suppl.)):127-134.
25. Ndeffo Mbah M.L., Kjetland E.F., Atkins K.E., et al. Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(19):7952-7957.
26. Ndeffo Mbah M.L., Poolman E., Atkins K.E., et al. Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa - the case of Zimbabwean women. PLoS Negl. Trop. Dis. 2013, 7(8):e2346.
27. Poole D., Raftery A.E. Inference for deterministic simulation models: the Bayesian melding approach. J. Am. Stat. Assoc. 2000, 95(December (452)):1244-1255.
28. Richter J., Poggensee G., Kjetland E.F., Helling-Giese G., Chitsulo L., Kumwenda N., et al. Reversibility of lower reproductive tract abnormalities in women with Schistosoma haematobium infection after treatment with praziquantel - an interim report. Acta Trop. 1996, 62(December (4)):289-301.
29. Saltelli A., Ratto M., Andres T., Campolongo F., Cariboni J., Gatelli D., et al. Global Sensitivity Analysis: The Primer 2008, Wiley-Interscience. 1st ed.
30. Schur N., Utzinger J., Vounatsou P. Modelling age-heterogeneous Schistosoma haematobium and S. mansoni survey data via alignment factors. Parasitol. Vectors 2011, 4:142.
31. Spiegel J.M., Dharamsi S., Wasan K.M., Yassi A., Singer B., Hotez P.J., et al. Which new approaches to tackling neglected tropical diseases show promise?. PLoS Med. 2010, 7(May (5)):e1000255.
32. Steinmann P., Keiser J., Bos R., Tanner M., Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect. Dis. 2006, 6(July (7)):411-425.
33. Stillwaggon E. Living with uncertainty. Trends Parasitol. 2012, 28(July (7)):261-266.
34. Touré S., Zhang Y., Bosqué-Oliva E., Ky C., Ouedraogo A., Koukounari A., et al. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso. Bull. World Health Organ. 2008, 86(October (10)):780-787. A.
35. Utzinger J., Raso G., Brooker S., De Savigny D., Tanner M., Ornbjerg N., et al. Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology 2009, 136(November (13)):1859-1874.
36. World Health Organization Coordinated Use of Anthelminthic Drugs in Control Interventions - A Manual for Health Professionals and Programme Manager 2006, WHO press, Geneva.
37. World Health Organization AIDS Epidemic Update: December 2010 2012, Available from: http://www.who.int/hiv/pub/epidemiology/epiupdate2010/en/index.html (cited 11.4.12).
38. World Health Organization Report of an Informal Working Group Meeting on Urogenital Schistosomiasis and HIV Transmission 2010, WHO Press, Available from: http://whqlibdoc.who.int/hq/2010/WHO_HTM_NTD_PCT_2010.5_eng.pdf (cited 2.10.12).
39. World Health Organization Global Health Observatory Data Repository 2014, Available from: http://apps.who.int/ghodata/.